Allogeneic Hematopoietic Cell Transplantation Clinical Trial
Official title:
Healthcare Associated Infection Reduction in Stem Cell Transplant Patients: a Randomized, Double-blind, Placebo-controlled Study Evaluating Twice Daily Xylitol Administration
The central hypothesis is that daily dental xylitol wipes, in addition to current oral care practice, are effective at reducing BSI from oral organisms, and decreasing the incidence of gingivitis, oral plaque, and oral ulcerations after SCT.
Our long-term goal is to develop and disseminate clinically relevant, and easily adoptable strategies to prevent BSI and improve outcomes after SCT. The overall objective of this proposal is to identify a clinically effective strategy to prevent or reduce BSI secondary to bacterial translocation through oral injured mucosa . ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03678493 -
A Study of FMT in Patients With AML Allo HSCT in Recipients
|
Phase 2 | |
| Terminated |
NCT04088760 -
TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders
|
Phase 2 | |
| Completed |
NCT03302754 -
Precision Dosing of Alemtuzumab
|
N/A | |
| Not yet recruiting |
NCT02506231 -
The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04332341 -
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
|
Early Phase 1 | |
| Recruiting |
NCT05501756 -
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
|
Phase 2 | |
| Completed |
NCT00888316 -
Iron Overload in Patients Undergoing Donor Stem Cell Transplant
|
N/A |